A panel of the US FDA has recommended that biotechnologist Novavax’s corona vaccine be approved for adults. If the FDA follows the panel’s recommendation, which it usually does within days, Novavax will become the fourth US-approved corona vaccine, alongside those from Pfizer/BioNTech, Moderna and Johnson & Johnson (Janssen).
ttn-43
US regulator’s panel recommends approval of Novavax corona vaccine
